CCF FY2021 Solicitation
FY2021 Announcements
Congratulations to the 34 companies who were selected for funding during the FY21 solicitation! Read more about the inaugural CCF awards in a press release issued by Governor Northam. If you missed this year's opportunity please join our listserv to stay apprised of future rounds.
Information on this page will remain available through August 20, 2021.
Information on this page will remain available through August 20, 2021.
| |||||
General
CIT is conducting a competitive solicitation for young Virginia companies that have strong potential to drive economic growth in Virginia, including revenue and job creation, in strategically important industry sectors. The CCF FY21 round will provide grants up to $100,000 to advance companies and their highly promising technologies that have seen traction, for instance through revenue and/or investment, and would be catalyzed by support to commercialize the technologies or access the market. Up to $7 million has been allocated for the single FY21 round. Projects are anticipated to be 6-12 months and CCF funding can supports companies' commercialization goals through product or service development, pilots, intellectual property protection, marketing, and more.
Although this year's solicitation targets the private sector, future rounds will expand to include Virginia's colleges and universities and broader criteria. Stay tuned and make sure you're a part of our listserv to stay apprised of future opportunities.
The content that follows provides high-level program information. Review FY21 program guidelines for complete information about this round, including eligibility, the application process, evaluation criteria, and more.
CIT is conducting a competitive solicitation for young Virginia companies that have strong potential to drive economic growth in Virginia, including revenue and job creation, in strategically important industry sectors. The CCF FY21 round will provide grants up to $100,000 to advance companies and their highly promising technologies that have seen traction, for instance through revenue and/or investment, and would be catalyzed by support to commercialize the technologies or access the market. Up to $7 million has been allocated for the single FY21 round. Projects are anticipated to be 6-12 months and CCF funding can supports companies' commercialization goals through product or service development, pilots, intellectual property protection, marketing, and more.
Although this year's solicitation targets the private sector, future rounds will expand to include Virginia's colleges and universities and broader criteria. Stay tuned and make sure you're a part of our listserv to stay apprised of future opportunities.
The content that follows provides high-level program information. Review FY21 program guidelines for complete information about this round, including eligibility, the application process, evaluation criteria, and more.
Timeline
|
Qualified Industries
Projects submitted for consideration under the CCF FY21 round must directly align with one or more of the following industry sectors:
Most sectors are described in the October 2019 Commonwealth Research and Technology Strategic Roadmap; clean energy, cybersecurity, and data science and analytics are defined in the FAQs.
Projects submitted for consideration under the CCF FY21 round must directly align with one or more of the following industry sectors:
- Agricultural and environmental technologies
- Autonomous systems
- Cybersecurity
- Life and health sciences
- Clean energy
- Data science and analytics
- Space and satellites
Most sectors are described in the October 2019 Commonwealth Research and Technology Strategic Roadmap; clean energy, cybersecurity, and data science and analytics are defined in the FAQs.
Qualified Applicants
CCF is seeking applicants this round whose technologies align with one or more of the aforementioned industry sectors as well as the company criteria that follows.
In addition, applicants must align with the criteria outlined in one of the three following categories:
CATEGORY 1: Companies whose CCF-supported technology does not require FDA approval
CATEGORY 2: Companies whose CCF-supported technology requires FDA New Drug Application (NDA) or Biologics License Application (BLA)
CATEGORY 3: Companies whose CCF-supported technology requires FDA Premarket Approval (PMA), 510(k) clearance (see also 1), or is on the De Novo pathway (see also 2)
Applicants must be in good standing with the Commonwealth of Virginia and federal government. Appendix A in the guidelines provides additional eligibility guidance.
CCF is seeking applicants this round whose technologies align with one or more of the aforementioned industry sectors as well as the company criteria that follows.
- Be a for-profit company headquartered in and with an express desire to grow the business in Virginia
- Be founded or otherwise legally formed on or after January 1, 2016 (a valid tax ID number is required)
- Virginia is the place of business for the CEO, CCF Project Manager, and majority of the company's other senior executives and staff
In addition, applicants must align with the criteria outlined in one of the three following categories:
CATEGORY 1: Companies whose CCF-supported technology does not require FDA approval
- Received between $500,000 and $1 million in combined capital investment, contracts, and/or grant funding for the CCF-supported product or service between July 1, 2019 and December 31, 2020 and/or generated revenue between $100,000 and $1 million for the CCF-supported product or service during the same period
- Had a minimal viable product (MVP) available by December 1, 2020
CATEGORY 2: Companies whose CCF-supported technology requires FDA New Drug Application (NDA) or Biologics License Application (BLA)
- Received at least $1 million in combined outside grants, revenue, and/or capital investment between July 1, 2019 and December 31, 2020
CATEGORY 3: Companies whose CCF-supported technology requires FDA Premarket Approval (PMA), 510(k) clearance (see also 1), or is on the De Novo pathway (see also 2)
- Received at least $500,000 in combined outside grants, contracts, and/or capital investment for the technology between July 1, 2019 and December 31, 2020
- (1) If the technology requires 510(k) clearance, companies must have received 510(k) clearance or have submitted their 510(k) application; a CCF award is contingent upon receiving 510(k) clearance
- (2) If the technology is on the De Novo pathway, companies must have had their De Novo request granted, have submitted their De Novo request, or have had a successful Q-Submission meeting with the FDA by December 31, 2020; a CCF award is contingent upon the De Novo request being granted
Applicants must be in good standing with the Commonwealth of Virginia and federal government. Appendix A in the guidelines provides additional eligibility guidance.
Program Details
- CCF funds may be used to support companies' commercialization and market entry goals that include but aren't limited to: product or service development, pilots, market research, marketing, intellectual property protection, and talent acquisition
- Maximum request / award amount: $100,000
- Matching funds of at least 1:1 to the funds requested from CCF are required; see Matching Funds section of the guidelines for fulfillment approach
- Applicants may submit one executive summary and subsequently one application (companies that are affiliated through ownership, common management or leadership, and/or other control are considered under the same umbrella and may participate through one total submission)
Applying for Funding
Companies seeking CCF funding in FY21 were required to submit an executive summary via the online portal between Thursday, January 7 and Monday, February 8 at noon. Late submission were not considered. Companies whose executive summaries scored the highest were invited to submit a full application consisting of an online form for administrative information, proposal, budget, and appendix. Program guidelines discuss the process, components, and evaluation criteria in greater detail.
Companies seeking CCF funding in FY21 were required to submit an executive summary via the online portal between Thursday, January 7 and Monday, February 8 at noon. Late submission were not considered. Companies whose executive summaries scored the highest were invited to submit a full application consisting of an online form for administrative information, proposal, budget, and appendix. Program guidelines discuss the process, components, and evaluation criteria in greater detail.
